New Yale research turns the standard story about GLP-1 drugs upside down: the hunger neurons do not switch off, they switch on.
🩺 Written by K.Y.J.A.M. Ho, MD PhD, medical specialist · reviewed by C. Pleiter, medical specialist · updated 24 August 2026 · sources & method
New research from Yale suggests that GLP-1 medicines such as Ozempic may not work by switching your hunger neurons off, but by switching them on. Those neurons appear necessary to mobilise fat and sustain weight loss, at least in mice. Hunger may not be an enemy to silence, but a system your body needs.
Do the check (1 minute) or jump straight to the science
Emerging Hunger neurons needed for lasting weight loss (mice) Strong Weight loss with semaglutide in humans is well established Strong Without a lifestyle foundation, much weight returns after stopping
This is educational information based on averages, not personal medical advice. Take these points to your own doctor and discuss what fits your situation. Never change medication on your own.
This check gives an indication only. It is not a medical test and makes no diagnosis. Discuss any doubt or symptoms with your doctor.
Deep in your brain, in the hypothalamus, sits a small group of nerve cells called AgRP neurons. They are known as the hunger neurons: when they fire, you go looking for food. For years the story was simple. Drugs like Ozempic and Wegovy (semaglutide) were thought to quiet these neurons, so you feel less hungry and lose weight.
Researchers at Yale have now put that story to the test, and it probably is not right. In mice, they found that long-term semaglutide treatment activates the hunger neurons instead. Even more striking: when the researchers disabled those neurons, the mice still ate less, yet the weight loss did not last. Within about two weeks they regained the weight. The problem was not appetite but fat tissue: without working hunger neurons, the body never got the signal to release fat as fuel.
The lesson fits what we keep saying at DrHealthy: hunger is not a defect and not an enemy. It is an ancient system that manages your energy reserves. Lasting fat loss does not come from shutting that system down, but from getting it to work with you. And to be fair: this is research in mice, mostly female mice. Whether it works exactly the same way in humans is not yet known.
If you use a GLP-1 medicine or are considering one, always discuss it with your own physician. This article is education, not medical advice.
No. The weight loss in humans is well established. This research is about how it works, not whether it works.
No. This is research in mice and no reason to change anything. Always discuss medication questions with your own physician.
Your hunger system is not broken, it is doing its job: defending your energy reserves. That is why lasting change is built around behaviour and metabolism instead of willpower.
Evidence labels: Strong = consistent randomised trials or meta-analyses matching the population and intervention · Moderate = randomised or solid observational evidence with limitations · Emerging = early, small or animal studies, not yet confirmed in humans.
What exactly was found? In PNAS (August 2026), d’Avila and colleagues from Tamas Horvath’s lab at Yale describe what happens when AgRP neurons are disabled or their activation is blocked in mice receiving semaglutide. The surprise came in three layers. First: with sustained treatment, AgRP neurons became activated, not inhibited. Second: mice without properly functioning AgRP neurons initially lost weight but regained it within roughly 15 days, even though they kept eating less. Third: fat mobilisation faltered. The shift toward fat burning did not hold and the animals reverted to burning carbohydrates. The researchers point to beta-3 adrenergic signalling toward fat tissue as a link in the sustained effect (animal study, clearest in female mice). Emerging
Why does this make sense? AgRP neurons are much more than a hunger switch. They are among the best studied energy sensors in the brain: activate them artificially and a mouse starts eating almost immediately, remove them in adult animals and eating nearly stops. They respond within seconds to the sight and smell of food, before a single bite is taken. A system like that coordinates the whole response to an energy deficit, including drawing on fat reserves. That a drug creating an artificial energy deficit would need this system is, in hindsight, not so strange. The underlying AgRP physiology has been repeatedly demonstrated in animals. Strong
What do we know for certain about GLP-1 drugs in humans? That semaglutide produces substantial average weight loss in people with overweight or obesity (around 15 percent in the STEP 1 trial) is firmly established in randomised research. Also well documented: after stopping, much of the weight returns when no lifestyle foundation is in place. Strong
What about the brain as the site of action? That the drug acts through the brain, including the arcuate nucleus where AgRP neurons live, was already known from earlier animal work with liraglutide and semaglutide, with indirect human evidence. Moderate to Strong
What do we not know yet? Whether this new mechanism applies to humans. The study was done in mice, most clearly in females, and part of the results depended on diet: on a high-fat diet the effects ran through different (dopaminergic) pathways. Translating this to the clinic would be premature. Emerging
The DrHealthy reading. This research supports a principle we build everything around: you do not lose fat sustainably by suppressing hunger, but by getting your metabolism to cooperate. Protein as the anchor of every meal, maintaining muscle with resistance training, a calm eating rhythm without constant snacking, and enough sleep all support exactly the systems in view here: satiety hormones, fat mobilisation and a brain that can manage an energy deficit properly. If you use a GLP-1 medicine, that foundation matters more, not less. And once again: decisions about medication belong with your own physician, never with a website. Also read: a weight-loss pill at the pharmacy soon, does that change everything?
This is general medical information, not a diagnosis or a treatment. For advice about your own situation, and before changing anything about your medication, always talk to your own doctor.
Explore more topics in our knowledge base →